Abstract: An example embodiment of the present invention provides a process that uses IP flow information to selectively notify users of an application server of the server's unavailability. In the example embodiment, the process, which might run on a system comprising a router, monitors IP flow records as to dropped packets and learns that an application server has become unavailable. The process then uses the IP flow records to identify active users of the application server, for example, by passing a source IP address to a presence service. Once the process has identified an active user, the process determines a means of notification for the user, which might be through the presence service, and transmits a notification to the user as to the unavailability of the application server. In the example embodiment, the process transmits a later notification as to the availability of the application server, using reverse camp-on functionality.

Abstract: An example embodiment of the present invention provides a process that uses IP flow information to selectively notify users of an application server of the server's unavailability. In the example embodiment, the process, which might run on a system comprising a router, monitors IP flow records as to dropped packets and learns that an application server has become unavailable. The process then uses the IP flow records to identify active users of the application server, for example, by passing a source IP address to a presence service. Once the process has identified an active user, the process determines a means of notification for the user, which might be through the presence service, and transmits a notification to the user as to the unavailability of the application server. In the example embodiment, the process transmits a later notification as to the availability of the application server, using reverse camp-on functionality.

Abstract: An active hydraulic ventricular attachable support system includes a net cover for surrounding a ventricle and is formed by hollow tubes. All the hollow tubes can completely communicate with each other or form a plurality of independent areas, and the interior of each independent area is intercommunicating, while the independent areas are not communicating with each other. The system as a whole is positioned on the surface of the heart. The hollow tubular structure can be filled with various kinds of liquid of different physical characteristics, and then the corresponding reaction pressure generated can be applied to the ventricle and the surfaces of the heart. The system also can be incorporated with local administration.

Abstract: An example embodiment of the present invention provides a process that uses IP flow information to selectively notify users of an application server of the server's unavailability. In the example embodiment, the process, which might run on a system comprising a router, monitors IP flow records as to dropped packets and learns that an application server has become unavailable. The process then uses the IP flow records to identify active users of the application server, for example, by passing a source IP address to a presence service. Once the process has identified an active user, the process determines a means of notification for the user, which might be through the presence service, and transmits a notification to the user as to the unavailability of the application server. In the example embodiment, the process transmits a later notification as to the availability of the application server, using reverse camp-on functionality.

Abstract: An example embodiment of the present invention provides a process that uses IP flow information to selectively notify users of an application server of the server's unavailability. In the example embodiment, the process, which might run on a system comprising a router, monitors IP flow records as to dropped packets and learns that an application server has become unavailable. The process then uses the IP flow records to identify active users of the application server, for example, by passing a source IP address to a presence service. Once the process has identified an active user, the process determines a means of notification for the user, which might be through the presence service, and transmits a notification to the user as to the unavailability of the application server. In the example embodiment, the process transmits a later notification as to the availability of the application server, using reverse camp-on functionality.

Abstract: In one embodiment, a user can send a message to all available, scheduled participants in a conference call by pressing a conference notification softkey. When this conference notification softkey is pressed, a message concerning the conference call appears on the display screen of the available scheduled participants.

Abstract: New pyrimidine or pyridine based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of disorders mediated by GSK3 activity, such as in the treatment of diabetes, Alzheimer's disease and other neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, essential hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency or cancer.

Abstract: New bicyclic based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of disorders mediated by GSK3 activity, such as in the treatment of diabetes, Alzheimer's disease and other neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, essential hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency or cancer.

Abstract: New pyrimidine or pyridine based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of disorders mediated by GSK3 activity, such as in the treatment of diabetes, Alzheimer's disease and other neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, essential hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency or cancer.

Abstract: New bicyclic based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of disorders mediated by GSK3 activity, such as in the treatment of diabetes, Alzheimer's disease and other neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, essential hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency or cancer.

Abstract: New pyrimidine or pyridine based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of disorders mediated by GSK3 activity, such as in the treatment of diabetes, Alzheimer's disease and other neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, essential hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency or cancer.

Abstract: Novel pyridine and pyrimidine derivatives which selectively inhibit glycogen synthase kinase 3 are provided and methods of preparing these compounds are provided. These compounds are useful in treating certain conditions which may be mediated by glycogen synthase kinase 3.

Abstract: New bicyclic based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of disorders mediated by GSK3 activity, such as in the treatment of diabetes, Alzheimer's disease and other neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, essential hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency or cancer.